Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 1
2001 2
2004 3
2008 1
2009 2
2010 9
2011 12
2012 17
2013 11
2014 14
2015 11
2016 15
2017 19
2018 14
2019 25
2020 20
2021 16
2022 23
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29934276

186 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Accuracy of Image-Guided Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Real-Life Clinical Practice: In Vivo Assessment Using Hepatic Parenchymal Changes on Gd-EOB-DTPA-Enhanced Magnetic Resonance Images.
Jung J, Kim H, Yoon SM, Cho B, Kim YJ, Kwak J, Kim JH. Jung J, et al. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):867-874. doi: 10.1016/j.ijrobp.2018.05.018. Epub 2018 May 14. Int J Radiat Oncol Biol Phys. 2018. PMID: 29934276
Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
Schelhorn J, Best J, Reinboldt MP, Gerken G, Ruhlmann M, Lauenstein TC, Antoch G, Kinner S. Schelhorn J, et al. J Vasc Interv Radiol. 2015 Jul;26(7):972-9. doi: 10.1016/j.jvir.2015.03.009. Epub 2015 Apr 27. J Vasc Interv Radiol. 2015. PMID: 25937296 Clinical Trial.
Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.
Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki Y, Mizuno T, Iwabuchi S, Kunieda E. Sanuki N, et al. Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):306-11. doi: 10.1016/j.ijrobp.2013.10.045. Int J Radiat Oncol Biol Phys. 2014. PMID: 24411601
Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
Takamatsu S, Yamamoto K, Maeda Y, Kawamura M, Shibata S, Sato Y, Terashima K, Shimizu Y, Tameshige Y, Sasaki M, Asahi S, Kondou T, Kobayashi S, Matsui O, Gabata T. Takamatsu S, et al. PLoS One. 2016 Dec 1;11(12):e0167155. doi: 10.1371/journal.pone.0167155. eCollection 2016. PLoS One. 2016. PMID: 27907063 Free PMC article.
Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J. Ichikawa T, et al. Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b. Invest Radiol. 2010. PMID: 20098330 Clinical Trial.
186 results